NCT03172221View on ClinicalTrials.gov

Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women

CompletedOBSERVATIONAL

Enrollment

880

Participants

Timeline

Start Date

July 25, 2017

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Plasmodium FalciparumPregnancy MalariaDiagnoses Disease

Interventions

DIAGNOSTIC_TEST

HS-RDT

A single finger-prick blood sample will be collected and used to test participants with the HS-RDT. The results of the results of the test will not be used for treatment purposes nor used to inform patient care.

Trial Locations (2)

Unknown

Centro de Salud el Reposo, Quibdó

Hospital Divino Nino, Tumaco

All Listed Sponsors

collaborator

Universidad de Antioquia

OTHER

lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER

NCT03172221 - Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women | Biotech Hunter | Biotech Hunter